Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Prostacyclin Receptor Agonist [EPC]

Known as: Prostacyclin Receptor Agonist 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Abstract 1. The metabolism of selexipag has been studied in vivo in man and the main excreted metabolites were identified. Also… Expand
Is this relevant?
2018
2018
Abstract 1. This study examined the pharmacokinetics, distribution, metabolism and excretion of the selective prostacyclin… Expand
Is this relevant?
2017
2017
BACKGROUND Selexipag is an orally available prostacyclin receptor (IP receptor) agonist with a non-prostanoid structure. In this… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?